This report contains market size and forecasts of C Difficile Infection Drug in global, including the following market information:
Global C Difficile Infection Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global C Difficile Infection Drug Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five C Difficile Infection Drug companies in 2021 (%)
The global C Difficile Infection Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Metronidazole Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of C Difficile Infection Drug include Merck, Astellas, Eli Lilly, ANI Pharmaceutical, Flynn Pharma, Aspen Pharmacare, Akorn, Merus labs and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the C Difficile Infection Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global C Difficile Infection Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global C Difficile Infection Drug Market Segment Percentages, by Type, 2021 (%)
Metronidazole
Vancomycin
Fidaxomycin
Others
Global C Difficile Infection Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global C Difficile Infection Drug Market Segment Percentages, by Application, 2021 (%)
Pre-treatment
Mid-term treatment
Others
Global C Difficile Infection Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global C Difficile Infection Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies C Difficile Infection Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies C Difficile Infection Drug revenues share in global market, 2021 (%)
Key companies C Difficile Infection Drug sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies C Difficile Infection Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Astellas
Eli Lilly
ANI Pharmaceutical
Flynn Pharma
Aspen Pharmacare
Akorn
Merus labs
Pfizer
AstraZeneca
Strides
Sanofi
Fresenius
Xellia
Zhejiang Medicine
Lupin